Novel Family of Gynecologic Cancer Antigens Detected by Anti-HIV Antibody
Author Information
Author(s): Ewa M. Rakowicz-Szulczynska, David G. McIntosh, Peter Morris, McClure Smith
Primary Institution: University of Nebraska Medical Center
Hypothesis
The reactivity of gynecologic cancer proteins with monoclonal antibody directed against HIV-I was tested.
Conclusion
The identified antigens may represent either the products of human genes or the products of an unknown virus specifically expressed in female cancer.
Supporting Evidence
- Three antigens were detected in various gynecologic cancers using a monoclonal antibody against HIV-I.
- Antigens p120 and p41 were not found in normal ovarian tissue.
- All tested cervical cancer samples expressed the antigens p120, p41, and p24.
Takeaway
Researchers found new proteins in female cancers that might be linked to HIV, which could help in diagnosing these cancers.
Methodology
Cytoplasmic and nuclear proteins from various gynecologic cancers were tested using Western blotting with monoclonal antibodies against HIV-I.
Limitations
The study does not confirm the viral etiology of female malignancies beyond cervical cancer.
Participant Demographics
Patients with various types of gynecologic cancers including cervical, ovarian, endometrial, vulvar, and mixed millerian tumors.
Want to read the original?
Access the complete publication on the publisher's website